Advertisement

Topics

Latest "CFS B.V." News Stories

05:33 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "CFS B.V." found in our extensive news archives from over 250 global news sources.

More Information about CFS B.V. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about CFS B.V. for you to read. Along with our medical data and news we also list CFS B.V. Clinical Trials, which are updated daily. BioPortfolio also has a large database of CFS B.V. Companies for you to search.

Showing News Articles 1–25 of 430,000+

Tuesday 18th December 2018

Teva reports positive results for fremanezumab in phase IIIb migraine trial

The trial was held in patients who previously experienced inadequate responses to two to four classes of preventive treatments. In the study of 838 patients, including those who The post Teva reports positive results for fremanezumab in phase IIIb migraine trial appeared first on Pharmaceutical Business review.


Vedanta begins phase 2 trial of LBP candidate VE303 for rCDI

VE303 is claimed to be the first drug featuring a rationally-defined bacterial consortium to advance to phase 2 study. The earlier announced phase 1a/1b study showed rapid, durable, The post Vedanta begins phase 2 trial of LBP candidate VE303 for rCDI appeared first on Pharmaceutical Business review.

Spectral Medical Inc EDT Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummarySpectral Medical Inc Spectral, formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company's products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, which is used as diagnostic for endotoxemia. Spectral's toraymyxin is a polymyxin B extracorporeal direct ...


Icon Genetics GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryIcon Genetics GmbH Icon Genetics, a subsidiary of Denka Co Ltd, is a technology company that offers plant engineering technologies. The company develops, manufactures and markets biopharmaceutical product candidates, engineered organisms and technology platforms for plant biotechnology and plantbased production. It commercializes proprietary transgene operating systems suites of technologie...

6 tweets that defined cancer policy in 2018

Merit Medical Systems buys medical devices maker Vascular Insights

Based in Quincy of Massachusetts, Vascular Insights is engaged in the design, development and manufacturing and marketing of medical devices for the minimally invasive treatment of peripheral vascular The post Merit Medical Systems buys medical devices maker Vascular Insights appeared first on Compelo Medical Devices.

Notal Vision works with Wasatch Photonics to develop AI-enabled home-based optical coherence tomography

The first targeted application of the Notal Home OCT is to monitor exudative (wet) age-related macular degeneration (eAMD) patients between scheduled, standard-of-care examinations by their treating retinal specialist. The post Notal Vision works with Wasatch Photonics to develop AI-enabled home-based optical coherence tomography appeared first on Compelo Medical Devices.

Imagion Biosystems, Planet Innovation to develop for MagSense instrument

Together the two companies will work on design concepts and the development of prototype systems that can be used by Imagion in its key pivotal clinical study for The post Imagion Biosystems, Planet Innovation to develop for MagSense instrument appeared first on Compelo Medical Devices.

CSPC Pharma to develop I─Mab Biopharma's long─acting GLP─1 Fc programme in China

I─Mab Biopharma (I─Mab), a China─based clinical stage biopharmaceutical company, and CSPC Pharmaceutical Group Co., Ltd. (CSPC), a leading pharmaceutical group in China, jointly announced a

State FDA ties up with SBTC to train blood banks on self audit exercise for effective compliance

In order to initiate self─audit exercise by blood banks in Nagpur and Konkan regions, the Maharashtra Food and Drug Administration (FDA) has collaborated with State Blood Transfusion Council (SBTC) to train

Australia Anesthesia and Respiratory Devices Market Outlook to 2025 Anesthesia Machines, Airway and Anesthesia Devices, Respiratory Devices and Others [Report Updated: 19102018] Prices from USD $5096

Australia Anesthesia and Respiratory Devices Market Outlook to 2025 Anesthesia Machines, Airway and Anesthesia Devices, Respiratory Devices and OthersSummaryGlobalData's new report, Australia Anesthesia and Respiratory Devices Market Outlook to 2025, provides key market data on the Australia Anesthesia and Respiratory Devices market. The report provides value, in millions of US dollars, volume in...

Acute Asthma Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2125

Acute Asthma Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Acute Asthma Global Clinical Trials Review, H2, 2018" provides an overview of Acute Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted acr...

Early life exposure to antibiotics and acid suppressants increases obesity risk

Exposure to antibiotics and acid suppressants in the first two years of life is associated with an increased risk of obesity later in childhood, particularly if prescribed in combination, study results show.

Safe Evaporative Sample Preparation of High Potency APIs

Genevac, an SP Scientific brand, recently provided a leading pharmaceutical company with a glovebox-enclosed version of its EZ-2 centrifugal evaporator to safely remove solvents from cytotoxic drug preparations. Cytotoxic drugs are used widely in the treatment of cancers as well as other diseases. Antibody drug conjugates are a class of highly potent therapeutic drugs used for treat...

Horizon Discovery Group plc enters an exclusive partnership with C4X Discovery Holdings plc to validate targets and develop next-generation oncology drugs

Cambridge, UK, 17 December 2018: Horizon Discovery Group plc (AIM: HZD), a global leader in the application of gene editing and gene modulation technologies, today announces that it has entered into an exclusive target discovery partnership with C4X Discovery Holdings plc (AIM: C4XD) ("C4XD"), a pioneering drug discovery company. The partnership aims to validate the novel synthetic ...

Teething products containing lidocaine made P medicine

Teething products which contain lidocaine will only be sold as a pharmacy-only medicine from 2019, the UK’s drugs safety watchdog has announced.

Why is it so hard to reproduce medical research results?

Reproducibility is a well-known problem in scientific circles; many academics and research firms find it persistently challenging to replicate potentially...Read More... The post Why is it so hard to reproduce medical research results? appeared first on Pharmaceutical Technology.

Universal Church “Enough Is Enough” Service Helps People Find Real Change

The service addressed common emotional issues and addictions and provided information and testimonials about how to get on the path towards a complete transformation. NEWARK, N.J. (PRWEB) December 18, 2018 The Universal Church of the Kingdom of God, a global evangelical church headquartered at the Temple of Solomon in São Paulo, Brazil, organized a service on November 16, 2018 that focused o...

PredictImmune Makes Further Strides Towards January Launch of PredictSURE IBD™, by Gaining ISO 13485 Medical Devices Certification

Certification demonstrates PredictImmune’s on-going commitment to the provision of high-quality processes to support the development of its in-vitro diagnostic pipeline PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today announced confirmation of its ...

Biofortuna Ltd Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750

SummaryBiofortuna Ltd Biofortuna is a provider of contract services and molecular diagnostic products. The company distributes CEmarked and freezedried PCR diagnostic kits. It has freeze dried molecular diagnostic products targeted at the transplantation, disease identification and pharmacogenetic markets. Biofortuna offers contract development and manufacturing services. The company also offers c...

Weekend Unlimited Inc. Appoints Mr. Paul Chu as President and CEO

Company appoints seasoned consumer packaged goods leader to bring and grow acquired brands to Canada, Jamaica, the United States and other international markets VANCOUVER, BC / ACCESSWIRE / Decembe...

United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2025 Anesthesia Machines, Airway and Anesthesia Devices, Respiratory Devices and Others [Report Updated: 19102018] Prices from USD $5096

United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2025 Anesthesia Machines, Airway and Anesthesia Devices, Respiratory Devices and OthersSummaryGlobalData's new report, United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2025, provides key market data on the United Kingdom Anesthesia and Respiratory Devices market. The report provides value, in millions of US dol...

DEA awards Contract to Magritek Inc. to Supply 80 MHz Benchtop NMR Spectrometers Complete with Autosamplers for Use in Forensic Applications

Magritek, a leading provider of compact NMR instruments reports being awarded a contract to supply two automated Spinsolve 80 MHz benchtop NMR spectrometers for forensic applications. Magritek announces that it has been awarded a major contract by the US Drug Enforcement Administration (DEA) for two Spinsolve 80 Carbon benchtop NMR spectrometers. The purchase was made through a competitive award p...

Researchers at Oxford Brookes University use the ZetaView® from Analytik Partner, Particle Metrix, to Study Extracellular Vesicles.

Analytik, leading suppliers of innovative analytical instrumentation, report on their Particle Metrix ZetaView® users at Oxford Brookes University who are studying extracellular vesicles. Dr Genevieve Melling is a postdoctoral researcher in the Department of Biological and Medical Sciences at Oxford Brookes University. She works in the laboratory of Dr Dave Carter which has been established to...

IRW-News: Weekend Unlimited Inc.: Weekend Unlimited Inc. ernennt Herrn Paul Chu zum President und CEO

IRW-PRESS: Weekend Unlimited Inc.: Weekend Unlimited Inc. ernennt Herrn Paul Chu zum President und CEO Weekend Unlimited Inc. ernennt Herrn Paul Chu zum President und CEO Das Unternehmen holt den ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks